Although PVC remains the polymer of choice in medical applications, with approximately 40% market share, widely publicized (and some might say overblown) health concerns involving some plasticizers used in PVC along with environmental issues have buoyed the fortunes of alternative materials. That is cited as one of the factors driving growth in the styrenic polymers market for medical applications by Transparency Market Research. A market report from the company projects a compound annual growth rate of 7.5% for the material in the medical sector through 2020.
Valued at $2.08 billion in 2013, styrenic polymers are expected to reach $3.29 billion in medtech applications by 2020, according to the market research firm. The material is used in applications ranging from the manufacture of medical devices to pharmaceutical packaging.